Bail in Buprenorphine Commercial Quantity Cases: Insights from Key Judgments

Possessing narcotics like Buprenorphine in commercial quantities can lead to severe legal consequences under India's Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985. One pressing question for those involved or their advocates is: Provide me Judgement Relating to Bail of Accused having Buprenorphine in Commercial Quantity. This blog post delves into the legal principles, judicial precedents, and critical factors courts consider when deciding bail applications in such cases. While this provides general information based on established judgments, it is not legal advice—consult a qualified lawyer for specific situations.

What Constitutes Commercial Quantity of Buprenorphine?

Under the NDPS Act, commercial quantity is defined as any quantity greater than the amount specified by the Central Government. For Buprenorphine, the commercial quantity threshold is 250 grams, while small quantity is 5 grams 2008 0 Supreme(UK) 483. However, other sources clarify nuances, particularly for liquid forms. The Indian Pharmacopoeia (1996) sets the commercial quantity of Buprenorphine in liquid form at 20 grams, equivalent to approximately 66,666.60 ml, though practical cases often reference lower effective thresholds like 20 ml for certain injections 2025 Supreme(Online)(MP) 6031.

In practice, seizures are measured in milliliters from injections. For instance:- 20 injections of 2 ml each (total 40 ml) was deemed slightly above commercial quantity 2022 0 Supreme(P&H) 2067.- 180 ml (90 ampoules of 2 ml) clearly fell under commercial quantity 2025 Supreme(Online)(Chh) 10606.- 22 milliliters was noted as marginally above, with commercial quantity above 20 milligrams 2020 0 Supreme(P&H) 686.

Courts emphasize accurate quantification: the actual weight of the narcotic substance, not the total mixture weight, determines the category 2009 2 Supreme 284. Conflicting forensic reports may favor the accused 2008 8 Supreme 12.

Stringent Bail Restrictions under Section 37 of NDPS Act

Section 37 imposes rigorous conditions for bail in commercial quantity cases 2022 0 Supreme(UK) 474 2023 2 Supreme 755. The court must be satisfied on two counts:1. Reasonable grounds to believe the accused is not guilty of the offense 2023 2 Supreme 755.2. The accused is not likely to commit any offense while on bail 2023 2 Supreme 755.

These twin conditions reflect the offense's gravity, prioritizing public safety over routine bail grants. Possession of commercial quantities triggers these restrictions, making bail harder compared to smaller quantities 2008 0 Supreme(UK) 483.

Judicial Approach: When Bail is Granted or Denied

Bail Granted in Borderline or Lesser Quantities

Courts are more lenient when quantities fall below commercial thresholds, even if significant. For example, bail has been granted where recoveries were less than commercial, as Section 37's rigor does not apply 2023 0 Supreme(UK) 11 2020 0 Supreme(UK) 71 2023 0 Supreme(UK) 45.

In marginally above cases, like 12 injections of Buprenorphine (little over commercial quantity), courts have referenced prior grants, such as in Suraj @ Saroj v. State of U.T., Chandigarh (13 injections totaling 26.26 gms) 2019 0 Supreme(P&H) 1946. Similarly, 22 ml was argued as only marginally above 2020 0 Supreme(P&H) 686.

Bail Denied in Clear Commercial Quantity Cases

Conversely, substantial recoveries lead to refusals. In a case with 180 ml, bail was opposed due to commercial quantity and offense gravity 2025 Supreme(Online)(Chh) 10606. Another involved 750 ampoules of Buprenorphine (Lupigesic), far exceeding limits, with chemical certification confirming it 2014 0 Supreme(Ker) 201. Courts dismissed bail holding it attracted Section 37 2011 0 Supreme(Ker) 488.

For 20 ml of Leegesic Buprenorphine injection (above 20 ml threshold), distinctions from co-accused were noted, impacting bail 2024 Supreme(Online)(CG) 7508. Seizures of 80 ml or 120 ml consistently categorized as commercial led to denials 2024 Supreme(Online)(CHH) 11245.

Since it was found that the accused were in possession of 750 ampoules of Buprenorphine (Lupigesic) - psychotropic substance it was found to be commercial quantity 2014 0 Supreme(Ker) 201.

Key Factors Courts Consider for Bail

Beyond quantity, courts evaluate:- Criminal History: Prior records heighten refusal likelihood 2023 0 Supreme(UK) 45 2024 2 Supreme 468. No antecedents may aid borderline cases 2025 Supreme(Online)(CHH) 3299 2023 0 Supreme(P&H) 1718.- Recovery Circumstances: Unexplained possession, supply role, or co-accused presence weigh against bail 2025 Supreme(Online)(CHH) 2283 2025 Supreme(Online)(CHH) 2271.- Investigation Status: Complete probes and filed challans (e.g., 12 injections case) still scrutinize under Section 37 2019 0 Supreme(P&H) 1946.- Forensic Reliability: Prosecution must prove composition accurately; doubts favor accused 2008 8 Supreme 12.

Quantity remains pivotal: The quantity of the recovered substance is a key factor in determining bail 2023 0 Supreme(UK) 45 2024 2 Supreme 468.

Integrating Broader Precedents and Implications

Judgments underscore NDPS's intent to curb trafficking. In Salam s/o Abdul Kader vs. Kerala High Court (SCC 2021), courts stressed non-guilt belief for commercial cases 2025 Supreme(Online)(P&H) 7108. Even with Diazepam or accessories like syringes, large Buprenorphine hauls (e.g., 750 ampoules + 95 Phenergan) clinch commercial intent 2014 0 Supreme(Ker) 1015.

Firstly, the alleged confiscation was of 20 injections of Buprenorphine of 2 ml each which comes to total of 40 ml, which is slightly higher than the commercial quantity under the NDPS Act... Since the alleged recovery is pertaining to commercial quantity, this Court would consider the prayer of the petitioner in the light of Section 37 of the NDPS Act 2022 0 Supreme(P&H) 2067.

Conclusion and Key Takeaways

Bail for Buprenorphine commercial quantity possession hinges on satisfying Section 37's strict twin conditions. Courts typically deny bail for quantities well above thresholds (e.g., 40 ml, 180 ml, 750 ampoules), citing gravity and risks 2023 2 Supreme 755. Marginal excesses or sub-commercial amounts may succeed, especially sans priors.

Key Takeaways:- Focus on pure narcotic weight, not mixture 2009 2 Supreme 284.- Prosecution needs solid forensics.- Accused history and reoffending risk are crucial 2023 0 Supreme(UK) 45.- Always below-commercial? Easier bail path 2023 0 Supreme(UK) 11.

This analysis draws from precedents like 2022 0 Supreme(UK) 474 2024 2 Supreme 468, offering general guidance. For personalized advice, engage legal experts promptly.